Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Class A Common Stock, par value $0.0001 per share
-
Shares outstanding
-
12.4M
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
24.9M
-
Shares change
-
-3.11M
-
Total reported value, excl. options
-
$36.6M
-
Value change
-
-$4.94M
-
Number of buys
-
36
-
Number of sells
-
-18
-
Price
-
$1.47
Significant Holders of P3 Health Partners Inc. - Class A Common Stock, par value $0.0001 per share (PIII) as of Q3 2023
75 filings reported holding PIII - P3 Health Partners Inc. - Class A Common Stock, par value $0.0001 per share as of Q3 2023.
P3 Health Partners Inc. - Class A Common Stock, par value $0.0001 per share (PIII) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.9M shares
.
Largest 10 shareholders include AMERIPRISE FINANCIAL INC (5.44M shares), JANUS HENDERSON GROUP PLC (3.78M shares), VANGUARD GROUP INC (2.58M shares), BlackRock Inc. (2.38M shares), FMR LLC (2.37M shares), Alyeska Investment Group, L.P. (1.96M shares), EMFO, LLC (1M shares), GEODE CAPITAL MANAGEMENT, LLC (801K shares), MILLENNIUM MANAGEMENT LLC (756K shares), and STATE STREET CORP (651K shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.